Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
News18 » Business
1-min read

Strides Pharma Suspends Sale of Ranitidine Tablets in US

Ranitidine tablets is amongst the top 5 products sold by Strides Pharma in the US.

PTI

Updated:September 27, 2019, 11:34 AM IST
facebookTwitterskypewhatsapp
Strides Pharma Suspends Sale of Ranitidine Tablets in US
Representative image.

New Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health regulator to provide test data related to impurities in the drug.

Ranitidine tablets are used to treat peptic ulcers of the stomach and intestines.

Data related to N-nitrosodimethylamine impurities is to be provided to the agency in 30 days.

"While the company conducts the relevant tests mandated by the the United States Food and Drug Administration (USFDA), it has suspended sales of Ranitidine tablets in the US market until such time it has clarity of next steps as would be indicated by the USFDA," Strides Pharma Science said in a BSE filing.

The company said it predominantly sells Ranitidine tablets in the US markets, and its front end sales globally for the product stood at $9 million in the first half of the current financial year.

Ranitidine tablets is amongst the top 5 products sold by the company in the USA.

Strides Pharma Science said in spite of this temporary suspension of the Ranitidine supplies, the company retains its growth outlook for the current financial year for the US markets.

The company's shares were trading 4.61 per cent lower at Rs 313.45 apiece on the BSE.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Read full article
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp
Most Active
Company Price Change %Gain
Yes Bank 51.40 8.44
Reliance 1,416.35 1.42
Indiabulls Hsg 231.20 16.80
Zee Entertain 250.20 -5.39
Maruti Suzuki 7,302.30 2.50
Company Price Change %Gain
HDFC AMC 2,882.20 6.11
Yes Bank 51.40 8.44
Indiabulls Hsg 231.50 17.42
Reliance 1,415.30 1.37
IRCTC 779.20 7.57
Top Gainers
Company Price Change %Gain
Yes Bank 51.40 8.44
Coal India 205.95 3.28
Adani Ports 421.70 3.07
Grasim 746.50 3.03
Maruti Suzuki 7,302.30 2.50
Company Price Change %Gain
Yes Bank 51.40 8.44
Coal India 205.95 3.31
Maruti Suzuki 7,318.15 2.74
Power Grid Corp 202.55 2.45
NTPC 121.00 2.02
Top Losers
Company Price Change %Gain
Zee Entertain 250.20 -5.39
Tata Motors 136.85 -1.90
Eicher Motors 20,275.90 -1.05
Bajaj Auto 3,087.05 -0.79
Hindalco 187.40 -0.74
Company Price Change %Gain
Tata Motors 136.70 -1.05
Bajaj Auto 3,087.75 -0.73
Bharti Airtel 383.25 -0.65
ICICI Bank 437.75 -0.64
Axis Bank 709.20 -0.19

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results